151 related articles for article (PubMed ID: 26405782)
1. Screening for colorectal cancer in Italy: 2011-2012 survey.
Zorzi M; Mangone L; Anghinoni E; Baracco S; Borciani E; Caldarella A; Falcini F; Fanetti AC; Ferretti S; Giorgi Rossi P; Michiara M; Randi G; Stracci F; Vicentini M; Zucchetto A; Zappa M;
Epidemiol Prev; 2015; 39(3 Suppl 1):108-14. PubMed ID: 26405782
[TBL] [Abstract][Full Text] [Related]
2. Screening for colorectal cancer in Italy: 2011-2012 survey.
Zorzi M; Mangone L; Sassatelli R; Baracco S; Budroni M; Castaing M; Cirilli C; Cusimano R; Fusco M; Giacomin A; Giorgi Rossi P; Naldoni C; Pannozzo F; Piffer S; Puppo A; Tisano F; Zappa M;
Epidemiol Prev; 2015; 39(3 Suppl 1):115-25. PubMed ID: 26405783
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
[TBL] [Abstract][Full Text] [Related]
5. [Screening for colorectal cancer in Italy, 2010 survey].
Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M
Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271
[TBL] [Abstract][Full Text] [Related]
6. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
7. Screening for colorectal cancer in Italy: 2006 survey.
Zorzi M; Falcini F; Fedato C; Grazzini G; de' Bianchi PS; Senore C; Vettorazzi M; Visioli C; Zappa M
Epidemiol Prev; 2008; 32(2 Suppl 1):55-68. PubMed ID: 18770995
[TBL] [Abstract][Full Text] [Related]
8. Screening for colorectal cancer in Italy: 2004 survey.
Zorzi M; Grazzini G; Senore C; Vettorazzi M
Epidemiol Prev; 2006; 30(1 Suppl 3):41-50. PubMed ID: 16937845
[TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal cancer in Italy: 2005 survey.
Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients with symptom- and screening-detected colorectal cancer.
Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
[TBL] [Abstract][Full Text] [Related]
11. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
[TBL] [Abstract][Full Text] [Related]
12. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
[TBL] [Abstract][Full Text] [Related]
13. Improved 5-year survival of patients with immunochemical faecal blood test-screen-detected colorectal cancer versus non-screening cancers in northern Italy.
Parente F; Vailati C; Boemo C; Bonoldi E; Ardizzoia A; Ilardo A; Tortorella F; Cereda D; Cremaschini M; Moretti R
Dig Liver Dis; 2015 Jan; 47(1):68-72. PubMed ID: 25306524
[TBL] [Abstract][Full Text] [Related]
14. Screening for colorectal cancer in Italy: 2007 survey.
Zorzi M; Fedato C; Naldoni C; Sassatelli R; Sassoli De' Bianchi P; Senore C; Visioli CB; Cogo C
Epidemiol Prev; 2009; 33(3 Suppl 2):57-74. PubMed ID: 19776487
[TBL] [Abstract][Full Text] [Related]
15. Screening for colorectal cancer in Italy, 2009 survey.
Zorzi M; Baracco S; Fedato C; Grazzini G; Sassoli De' Bianchi P; Senore C; Visioli CB; Cogo C
Epidemiol Prev; 2011; 35(5-6 Suppl 5):55-77. PubMed ID: 22166350
[TBL] [Abstract][Full Text] [Related]
16. Interval cancers after negative immunochemical test compared to screen and non-responders' detected cancers in Slovenian colorectal cancer screening programme.
Mlakar DN; Bric TK; Škrjanec AL; Krajc M
Radiol Oncol; 2018 Jul; 52(4):413-421. PubMed ID: 30511936
[TBL] [Abstract][Full Text] [Related]
17. Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy.
Carrozzi G; Sampaolo L; Bolognesi L; Sardonini L; Bertozzi N; Giorgi Rossi P; Zappa M; Baldissera S; Campostrini S; Ferrante G; Masocco M; Minardi V; D'Argenzio A; Moghadam PF; Quarchioni E; Ramigni M; Trinito MO; Salmaso S;
Epidemiol Prev; 2015; 39(3 Suppl 1):9-18. PubMed ID: 26405772
[TBL] [Abstract][Full Text] [Related]
18. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
[TBL] [Abstract][Full Text] [Related]
20. Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study.
Cardoso R; Guo F; Heisser T; De Schutter H; Van Damme N; Nilbert MC; Tybjerg AJ; Bouvier AM; Bouvier V; Launoy G; Woronoff AS; Cariou M; Robaszkiewicz M; Delafosse P; Poncet F; Walsh PM; Senore C; Rosso S; Lemmens VEPP; Elferink MAG; Tomšič S; Žagar T; Lopez de Munain Marques A; Marcos-Gragera R; Puigdemont M; Galceran J; Carulla M; Sánchez-Gil A; Chirlaque MD; Hoffmeister M; Brenner H
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):711-723. PubMed ID: 35561739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
